A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
Separating densely packed molecules before imaging allows them to become visible for the first time.
The computational structural biology researcher continues to serve the department and the MIT life sciences community.
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
The 2nd Annual Research Slam featured three-minute talks on cutting-edge research from across MIT in an engaging public showcase and competition.